DOĞAN, S. Et Al. 2022. TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy. Clinical Rheumatology , vol.41, no.8 , 2341-2349.

DOĞAN, S., KİMYON, G., ÖZKAN, H., Kacmaz, F., Camdeviren, B., & KARAASLAN, İ., (2022). TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy. Clinical Rheumatology , vol.41, no.8, 2341-2349.

DOĞAN, SERDAR Et Al. "TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy," Clinical Rheumatology , vol.41, no.8, 2341-2349, 2022

DOĞAN, SERDAR Et Al. "TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy." Clinical Rheumatology , vol.41, no.8, pp.2341-2349, 2022

DOĞAN, S. Et Al. (2022) . "TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy." Clinical Rheumatology , vol.41, no.8, pp.2341-2349.

@article{article, author={SERDAR DOĞAN Et Al. }, title={TNF-alpha, IL-6, IL-10 and fatty acids in rheumatoid arthritis patients receiving cDMARD and bDMARD therapy}, journal={Clinical Rheumatology}, year=2022, pages={2341-2349} }